The formation of protein aggregates is well-established as a source of toxic GOF, as observed in neurodegenerative disorders such as Parkinson’s disease, amyotrophic lateral sclerosis, and familial British dementia associated with ITM2B [58], as well as in systemic amyloidosis [61]. Here, ITM2B is linked to primary systemic amyloidosis.